Pharmacokinetic and/or Pharmacodynamic Consequence of Multiple Drug Therapy

2021 ◽  
pp. 1226-1226
CHEST Journal ◽  
1994 ◽  
Vol 105 (2) ◽  
pp. 408-411 ◽  
Author(s):  
Charles M. Nolan ◽  
Robert E. Sandblom ◽  
Kenneth E. Thummel ◽  
John T Slattery ◽  
Sidney D. Nelson

Cancer ◽  
1976 ◽  
Vol 38 (5) ◽  
pp. 1882-1886 ◽  
Author(s):  
George P. Canellos ◽  
Stuart J. Pocock ◽  
Samuel G. Taylor ◽  
Mary E. Sears ◽  
David J. Klaasen ◽  
...  

2013 ◽  
Vol 6 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Dindayal Patidar ◽  
Mithun S. Rajput ◽  
Nilesh P. Nirmal ◽  
Wenny Savitri

Abstract Adverse drug reactions (ADR) are a significant cause of morbidity and mortality, often identified only post-marketingly. Improvement in current ADR reporting, including utility of underused or innovative methods, is crucial to improve patient safety and public health. Hospital-based monitoring is one of the methods used to collect data about drug prescriptions and adverse events. The aims of this study were to identify the most frequent ADRs recognized by the attending physicians, study their nature, and to target these ADRs in order to take future preventive measures. A prospective study was conducted over a 7-month period in an internal medicine department using stimulated spontaneous reporting for identifying ADRs. Out of the 254 admissions, 32 ADRs in 37 patients (14.56%) were validated from the total of 36 suspected ADRs in 41 patients. Female predominance was noted over males in case of ADRs. Fifty percent of total ADRs occurred due to multiple drug therapy. Dermatological ADRs were found to be the most frequent (68.75%), followed by respiratory, central nervous system and gastrointestinal ADRs. The drugs most frequently involved were antibiotics, antitubercular agents, antigout agents, and NSAIDs. The most commonly reported reactions were itching and rashes. Out of the 32 reported ADRs, 50% of the reactions were probable, 46.87% of the reactions were possible and 3.12% of the reactions were definite. The severity assessment done by using the Hartwig and Seigel scale indicated that the majority of ADRs were ‘Mild’ followed by ‘Moderate’ and ‘Severe’ reactions, respectively. Out of all, 75% of ADRs were recovered. The most potent management of ADRs was found to be drug withdrawal. Our study indicated that hospital based monitoring was a good method to detect links between drug exposure and adverse drug reactions. Adequate training regarding pharmacology and optimization of drug therapy might be helpful to reduce ADR morbidity and mortality.


2021 ◽  
pp. 20210052
Author(s):  
Ngoc-Nhu Jennifer Nguyen ◽  
Lilia Maria Sanchez ◽  
Mariam Yassa ◽  
Julie David ◽  
Mona El Khoury

Gigantomastia is an uncommon benign condition characterized by massive breast enlargement. It is most often due to hormonal imbalance secondary to puberty or pregnancy, or induced by a pharmacological agent but can also be idiopathic. Herein, we report a rare case of idiopathic gigantomastia in a 46-year-old female on antiepileptic multiple-drug therapy who underwent total bilateral mastectomy to relieve associated pain.


2000 ◽  
Vol 32 (7) ◽  
pp. 1716-1717 ◽  
Author(s):  
M Okamoto ◽  
N Yoshimura ◽  
I Nakai ◽  
H Nakajima ◽  
H Ushigome ◽  
...  

1972 ◽  
Vol 8 (5) ◽  
pp. 477-484 ◽  
Author(s):  
R.D. Rubens ◽  
E. Wiltshaw ◽  
E. Boesen ◽  
D.A.G. Galton

2014 ◽  
Vol 29 (2) ◽  
pp. 110-115 ◽  
Author(s):  
Scott D. Nelson ◽  
Joanne LaFleur ◽  
Emily Hunter ◽  
Melissa Archer ◽  
Carin Steinvoort ◽  
...  

Objective: Providing care to patients with comorbid medical problems may result in complicated, multiple drug therapy regimens, increasing the risk of clinically meaningful drug–drug interactions (DDIs). The purpose of this article is to describe the prevalence of DDIs and provide examples on how to identify and intervene on DDIs. Methods: We described DDI data from the Utah Drug Regimen Review Center, where adult Medicaid patients were reviewed by pharmacists from 2005 to 2009. Patients were selected by the number of prescriptions filled per month (>7) or having a high RxRisk score. Summary: A total of 8860 patients were reviewed, and 16.6% had at least 1 clinically meaningful DDI. Patients with DDIs were slightly younger (mean age 45.2 vs 48.2), more likely to be female (75.0% vs 68.9%), and had more prescriptions per month (13.4 vs 12.5) compared to patients without ( P < .001). Pharmacodynamic DDIs were more prevalent (80.2%) than pharmacokinetic. Pharmacodynamic DDIs mainly occurred with drugs used to treat psychiatric/seizure/sleep disorders (69.4%) and pain/migraine (56.6%). Pharmacokinetic DDIs mainly occurred with drugs used to treat psychiatric/seizure/sleep disorders (53.2%), cardiovascular diseases (46.3%), and infectious diseases (29.6%). Conclusions: Clinically meaningful DDIs are common in patients with complex medication regimens. A systematic approach for identifying DDIs, determining clinical significance, formulating patient-specific recommendations, and communicating recommendations is important in pharmacy practice.


Sign in / Sign up

Export Citation Format

Share Document